TCTC Holdings’s Repligen RGEN Stock Holding History

TCTC Holdings’s Portfolio RGEN Stock Details RGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-26	Closed	-$4.78K	–	567
2024 Q1	$4.78K	Buy	+26	New	+$4.95K	﹤0.01%	475

Other funds holding RGEN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return

TCTC Holdings's RGEN Position: Q2 2024 in Review

TCTC Holdings sold out of Repligen (RGEN) in Q2 2024, closing a stake of 26 shares — an estimated $4.78K sold.

TCTC Holdings first reported a position in RGEN in Q1 2024 and held it in 1 quarter. The position peaked at $4.78K in Q1 2024. 455 funds tracked by Wall St. Rank hold RGEN as of Q2 2024.

TCTC Holdings reported no remaining Repligen position as of Q2 2024 after selling out during the quarter.
TCTC Holdings sold 26 Repligen shares in Q2 2024, an estimated $4.78K.
TCTC Holdings first reported a position in Repligen in Q1 2024 and held it in 1 quarter.
TCTC Holdings's Repligen position peaked at $4.78K in Q1 2024.
455 funds tracked by Wall St. Rank held Repligen as of Q2 2024.

Based on TCTC Holdings's 13F filing for Q2 2024, filed 6 Aug 2024.